Quick verdict
Strut Health is the better pick for most patients on overall scoring. One of the cheapest legitimate compounded options in the US market thanks to a niche oral lozenge format. No membership fee, free shipping, free consults, and physician access included. Trade-off: lozenge bioavailability data is thin compared to standard injectable semaglutide.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Embla | Strut Health | |
|---|---|---|
| Starts from | $249/mo (+ med separate) | $99/mo (incl. medication) |
| Lock-in | 12-month commitment | Month-to-month |
| Time to prescription | 7 days | 3 days |
| Consultation type | Synchronous | Async |
| Affiliate network | Impact | Direct |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Embla | Strut Health | |
|---|---|---|
| Pricing transparency | 6/10 | 9/10 |
| Cancellation terms | 7/10 | 9/10 |
| Onboarding experience | 6/10 | 7/10 |
| Medication options | 7/10 | 6/10 |
| Member outcomes | 8/10 | 6/10 |
When to choose Embla
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
When to choose Strut Health
Cost-sensitive patients who want needle-free GLP-1 entry under $100/mo and don't mind a less-studied delivery format.
FAQ
Is Embla cheaper than Strut Health?
Can I switch from Embla to Strut Health mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →